LLY

999.26

-0.72%↓

JNJ

228.04

-0.74%↓

ABBV

209.97

-0.24%↓

UNH

391

-2.31%↓

AZN

181.67

-1.91%↓

LLY

999.26

-0.72%↓

JNJ

228.04

-0.74%↓

ABBV

209.97

-0.24%↓

UNH

391

-2.31%↓

AZN

181.67

-1.91%↓

LLY

999.26

-0.72%↓

JNJ

228.04

-0.74%↓

ABBV

209.97

-0.24%↓

UNH

391

-2.31%↓

AZN

181.67

-1.91%↓

LLY

999.26

-0.72%↓

JNJ

228.04

-0.74%↓

ABBV

209.97

-0.24%↓

UNH

391

-2.31%↓

AZN

181.67

-1.91%↓

LLY

999.26

-0.72%↓

JNJ

228.04

-0.74%↓

ABBV

209.97

-0.24%↓

UNH

391

-2.31%↓

AZN

181.67

-1.91%↓

Accueil・Liste d'Actions・NeoGenomics Inc

NeoGenomics Inc

Ouvert

8.27 -1.08

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

8.21

Max

8.44

Chiffres clés
By Trading Economics
Revenu	-7.2M -17M
Ventes	-3.5M 187M
BPA	0.01
Marge bénéficiaire	-9.164
Employés	2,500
EBITDA	-5.8M -567K

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+80.87% upside

Dividendes
By Dow Jones
Prochains Résultats	28 juil. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	7.1M 1.1B
Ouverture précédente	9.35
Clôture précédente	8.27

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

7.7 / 10.27 Support & Résistance

NeoGenomics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 mai 2026, 14:22 UTC

Principaux Mouvements du Marché

Coincheck Shares Rise on $65 Million KDDI Investment, Digital-Asset Alliance

14 mai 2026, 23:57 UTC

Acquisitions, Fusions, Rachats

Kakao: Stake Sales Aim to Secure Funds for Future Investments

14 mai 2026, 23:56 UTC

Acquisitions, Fusions, Rachats

Kakao: Share Sale to Lower Kakao Investment's Stake in Dunmau to 4.03%

14 mai 2026, 23:56 UTC

Acquisitions, Fusions, Rachats

Kakao: Affiliate Kakao Investment to Sell 2.3M Dunamu Shares on June 15

14 mai 2026, 23:56 UTC

Acquisitions, Fusions, Rachats

Kakao to Sell 6.55% Stake in Crypto Exchange Operator Dunamu to Hana Financial for KRW1.003T

14 mai 2026, 17:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 mai 2026, 17:13 UTC

Market Talk

Higher Interest Rates for Longer Seen Positive for Stablecoins -- Market Talk

14 mai 2026, 14:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 mai 2026, 14:43 UTC

Market Talk

Bitcoin Stabilizes After $630M ETF Outflow -- Market Talk

14 mai 2026, 11:48 UTC

Market Talk

Bitcoin Turns Slightly Lower Amid Inflation Concerns, Iran War -- Market Talk

14 mai 2026, 07:25 UTC

Market Talk

Bitcoin Edges Higher But Recovery Limited -- Market Talk

13 mai 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

13 mai 2026, 16:58 UTC

Market Talk

Change to Ethereum Staking Could Boost Prices, Says Grayscale -- Market Talk

13 mai 2026, 16:53 UTC

Market Talk

Bitcoin Retreats to Short-Term Resistance Levels -- Market Talk

13 mai 2026, 15:37 UTC

Market Talk

Bitcoin Moves Back Under $80K as Crypto Caution Remains -- Market Talk

13 mai 2026, 12:51 UTC

Market Talk

Bitcoin Turns Lower as Trump-Xi Meeting Eyed -- Market Talk

13 mai 2026, 07:44 UTC

Market Talk

Bitcoin Rises But Middle East Tensions Limit Gains -- Market Talk

13 mai 2026, 07:44 UTC

Market Talk

Global Energy Roundup: Market Talk

12 mai 2026, 20:35 UTC

Résultats

Fold Holdings: 1Q Total Verified Accounts Nearly 85,000, Added Close to 2,000 New Verified Accounts >FLD

12 mai 2026, 20:35 UTC

Résultats

Fold Holdings: 1Q Total Transaction Volume: $172M; 32% YoY Decrease >FLD

12 mai 2026, 20:34 UTC

Résultats

Fold Holdings: More Than 1,000 Fold Bitcoin Credit Cards in Circulation >FLD

12 mai 2026, 20:34 UTC

Résultats

Fold Holdings: Transaction Volumes Dn 32% YoY >FLD

12 mai 2026, 20:34 UTC

Résultats

Fold Holdings: Restructuring Fees on Bitcoin Gift Card to Drive Distribution >FLD

12 mai 2026, 17:25 UTC

Résultats

EToro Reports Sharp Drop in Crypto Trading. The Stock Falls. -- Barrons.com

12 mai 2026, 14:07 UTC

Principaux Mouvements du Marché

Coincheck Shares Rise on $65M KDDI Investment, Digital-Asset Alliance

12 mai 2026, 13:53 UTC

Market Talk

Bitcoin Seen Primed to Move Higher Following CPI Report -- Market Talk

12 mai 2026, 13:38 UTC

Market Talk

'Altcoin Season' Talk Premature, Says Coinbase -- Market Talk

12 mai 2026, 13:35 UTC

Market Talk

Bitcoin Stays Above $80k in Wider Crypto Pullback -- Market Talk

12 mai 2026, 11:42 UTC

Market Talk

Bitcoin Stays Under Pressure Amid U.S.-Iran Stalemate -- Market Talk

12 mai 2026, 11:41 UTC

Résultats

EToro Reports Sharp Drop in Crypto Trading. Why the Stock Is Rising. -- Barrons.com

Comparaison

Variation de prix

NeoGenomics Inc prévision

Objectif de Prix

By TipRanks

80.87% hausse

Prévisions sur 12 Mois

Moyen 14.94 USD 80.87%

Haut 25 USD

Bas 11 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

12 ratings

Achat

Maintien

Vente

Basé sur 12 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

7.7 / 10.27Support & Résistance

Recent bearish events outweigh bullish events.

All events are bearish.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.